Targeting prolyl-tRNA synthetase via a series of ATP-mimetics to accelerate drug discovery against toxoplasmosis.

Targeting prolyl-tRNA synthetase via a series of ATP-mimetics to accelerate drug discovery against toxoplasmosis.

Show other versions (1)

The prolyl-tRNA synthetase (PRS) is a validated drug target for febrifugine and its synthetic analog halofuginone (HFG) against multiple apicomplexan parasites including Plasmodium falciparum and Toxoplasma gondii. Here, a novel ATP-mimetic centered on 1-(pyridin-4-yl) pyrrolidin-2-one (PPL) scaffol...

Full description

Bibliographic Details
Main Authors:	Manickam Yogavel, Alexandre Bougdour, Siddhartha Mishra, Nipun Malhotra, Jyoti Chhibber-Goel, Valeria Bellini, Karl Harlos, Benoît Laleu, Mohamed-Ali Hakimi, Amit Sharma
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-02-01
Series:	PLoS Pathogens
Online Access:	https://doi.org/10.1371/journal.ppat.1011124

Similar Items

Targeting prolyl-tRNA synthetase via a series of ATP-mimetics to accelerate drug discovery against toxoplasmosis
by: Manickam Yogavel, et al.
Published: (2023-02-01)

ATP mimetics targeting prolyl-tRNA synthetases as a new avenue for antimalarial drug development
by: Siddhartha Mishra, et al.
Published: (2024-07-01)

Double drugging of prolyl-tRNA synthetase provides a new paradigm for anti-infective drug development.
by: Yogavel Manickam, et al.
Published: (2022-03-01)

Targeting prolyl-tRNA synthetase to accelerate drug discovery against malaria, leishmaniasis, toxoplasmosis, cryptosporidiosis, and coccidiosis.
by: Jain, V, et al.
Published: (2017)

Structure of prolyl-tRNA synthetase-halofuginone complex provides basis for development of drugs against malaria and toxoplasmosis
by: Jain, V, et al.
Published: (2015)

Structural basis of malaria parasite phenylalanine tRNA-synthetase inhibition by bicyclic azetidines
by: Manmohan Sharma, et al.
Published: (2021-01-01)

Aminoacyl tRNA synthetases as potential drug targets of the Panthera pathogen Babesia
by: Jyoti Chhibber-Goel, et al.
Published: (2019-10-01)

Drug targeting of aminoacyl-tRNA synthetases in Anopheles species and Aedes aegypti that cause malaria and dengue
by: Soumyananda Chakraborti, et al.
Published: (2021-12-01)

Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
by: Kurata, K, et al.
Published: (2023)

Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
by: Keiji Kurata, et al.
Published: (2023-01-01)

Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
by: Keiji Kurata, et al.
Published: (2023-02-01)

Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance
by: Mark A. Tye, et al.
Published: (2022-08-01)

Protein Translation Enzyme lysyl-tRNA Synthetase Presents a New Target for Drug Development against Causative Agents of Loiasis and Schistosomiasis.
by: Arvind Sharma, et al.
Published: (2016-11-01)

Control of fibrosis with enhanced safety via asymmetric inhibition of prolyl‐tRNA synthetase 1
by: Ina Yoon, et al.
Published: (2023-05-01)

Phosphocode-dependent glutamyl-prolyl-tRNA synthetase 1 signaling in immunity, metabolism, and disease
by: Eun-Young Lee, et al.
Published: (2023-10-01)

Dimerization of arginyl-tRNA synthetase by free heme drives its inactivation in plasmodium falciparum
by: Jain, V, et al.
Published: (2016)

An appended domain results in an unusual architecture for malaria parasite tryptophanyl-tRNA synthetase.
by: Sameena Khan, et al.
Published: (2013-01-01)

DWN12088, A Prolyl-tRNA Synthetase Inhibitor, Alleviates Hepatic Injury in Nonalcoholic Steatohepatitis
by: Dong-Keon Lee, et al.
Published: (2024-01-01)

Glutamyl-prolyl-tRNA synthetase 1 coordinates early endosomal anti-inflammatory AKT signaling
by: Eun-Young Lee, et al.
Published: (2022-10-01)

The zinc-binding domain of mammalian prolyl-tRNA synthetase is indispensable for catalytic activity and organism viability
by: Kommireddy Vasu, et al.
Published: (2021-03-01)

Sequential magnesium binding facilitates lysyl-tRNA synthetase to recognize ATP
by: Zhoufei Hei, et al.
Published: (2023-03-01)

Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as Plasmodium Cytoplasmic Prolyl-tRNA Synthetase Inhibitors
by: Okaniwa, Masanori, et al.
Published: (2021)

The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs
by: Pepper, L. R., et al.
Published: (2016)

Cardiomyocyte-Specific Loss of Glutamyl-prolyl-tRNA Synthetase Leads to Disturbed Protein Homeostasis and Dilated Cardiomyopathy
by: Jiangbin Wu, et al.
Published: (2023-12-01)

Origin and evolution of glutamyl-prolyl tRNA synthetase WHEP domains reveal evolutionary relationships within Holozoa.
by: Partho Sarothi Ray, et al.
Published: (2014-01-01)

Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapy.
by: Akira Shibata, et al.
Published: (2017-01-01)

No drug–drug interactions between selective prolyl‐tRNA synthetase inhibitor, bersiporocin, and pirfenidone or nintedanib in healthy participants
by: Wonsuk Shin, et al.
Published: (2024-01-01)

Adenosine-Mimicking Derivatives of 3-Aminopyrazine-2-Carboxamide: Towards Inhibitors of Prolyl-tRNA Synthetase with Antimycobacterial Activity
by: Vinod Sukanth Kumar Pallabothula, et al.
Published: (2022-10-01)

Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl‐tRNA synthetase inhibitor, in healthy subjects
by: Min Young Park, et al.
Published: (2023-07-01)

Pyrrolysyl-tRNA Synthetase, an Aminoacyl-tRNA Synthetase for Genetic Code Expansion
by: Ana Crnković, et al.
Published: (2016-06-01)

Aminoacyl-tRNA synthetases of the multi-tRNA synthetase complex and their role in tumorigenesis
by: Krishnendu Khan, et al.
Published: (2022-05-01)

Engagement Rules That Underpin DBL-DARC Interactions for Ingress of Plasmodium knowlesi and Plasmodium vivax Into Human Erythrocytes
by: Manickam Yogavel, et al.
Published: (2018-08-01)

Drug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparum
by: Manickam, Y, et al.
Published: (2018)

Expanding a tyrosyl-tRNA synthetase assay to other aminoacyl-tRNA synthetases
by: Charles J. Richardson, et al.
Published: (2015-09-01)

Glutamyl-Prolyl-tRNA Synthetase Regulates Epithelial Expression of Mesenchymal Markers and Extracellular Matrix Proteins: Implications for Idiopathic Pulmonary Fibrosis
by: Dae-Geun Song, et al.
Published: (2018-11-01)

Aminoacyl-tRNA Synthetases: On Anti-Synthetase Syndrome and Beyond
by: Angeles S. Galindo-Feria, et al.
Published: (2022-05-01)

Chimeric design of pyrrolysyl-tRNA synthetase/tRNA pairs and canonical synthetase/tRNA pairs for genetic code expansion
by: Wenlong Ding, et al.
Published: (2020-06-01)

Genomic analyses of aminoacyl tRNA synthetases from human-infecting helminths
by: Preeti Goel, et al.
Published: (2019-05-01)

Peptidyl tRNA Hydrolase Is Required for Robust Prolyl-tRNA Turnover in Mycobacterium tuberculosis
by: Francesca G. Tomasi, et al.
Published: (2023-02-01)

Aminoacyl‐tRNA synthetases in medicine and disease
by: Peng Yao, et al.
Published: (2013-02-01)